Abstract:Objective Childhood absence epilepsy(CAE)is one of the idiopathic generalized epilepsy syndrome,characterized by multiple typical absence seizures per day.The aim of this study was to investigate the effectiveness of medical treatment and prognosis of CAE patients from three hospitals in Beijing.Methods All patients were collected from the three hospitals between October 1999 and December 2005 as part of a research project to identify susceptibility genes of CAE with the same inclusion and exclusion criteria.The diagnostic criteria of CAE were proposed by the International League Against Epilepsy(ILAE) in 1989.Patients were treated in the three different hospitals.Doctors who collected the patients made a decision of choice of antiepileptic drugs.The effectiveness of medical treatment on seizures and the prognosis of the CAE patients were followed up.Results In a cohort of 339 patients fulfilled the diagnostic criteria of CAE proposed by the ILAE in 1989,296 of 339 patients met the inclusion criteria of this study,outcome was available in 240 of 296 patients.Among 240 patients,94 were males(39.2%) and 146 were females(60.8%).The onset age of absence seizures ranged from 3 years and 3 months to 12 years,with a peak around 4 to 8 years(72.5%) of age.Thirty nine patients(16.2%) had a history of febrile seizures.Eighteen patients(7.5%) had a family history of febrile seizures or epilepsy.Twelve patients(5%) subsequently had several generalized tonic-clonic seizures.One patient had a history of absence status epilepticus.All patients had electroencephalogram pattern with a bilateral symmetric and synchronous discharge of regular 3Hz spike-wave discharges after spontaneity or hyperventilation.Valproic acid(VPA) was the first choice of drug therapy in 234 patients.Seizures were controlled in 217 out of 234 patients by VPA monotherapy.Fifteen of 234 patients received clonazepam(7),nazepam(4),or lamotrigine(4) as an add-on therapy.All of their seizures were controlled.Lamotrigine was the first choice in 4 cases,3 of them were completely controlled.Topiramate was the first choice in 2 cases,one was also completely controlled.All patients were followed up for 2 to 7 years.One hundred fifty eight patients(65.8%) had withdrawn antiepileptic drugs,complete remission maintained for more than 1 year after withdrawal of medication in 96 patients.No seizure relapsed in patients after medication withdrawal.Complete remission maintained for more than 2 years on medication in 80 patients.Only 2 patients still had seizures on medication.Learning score in the school was beyond the middle level in 171 patients(71.3%).Conclusions VPA is the first-line drug for CAE.It is effective in the majority of patients.Lamotrigine and benzodiazepines appear to be effective in resistant absence seizures in combination with VPA.Typical CAE is an epileptic syndrome with an excellent prognosis.

Treatment and prognosis of childhood absence epilepsy in 240 patients:Application of modified diagnostic criteria of childhood absence epUepsy 1989

Clinical significance of two diagnostic criteria for childhood absence epilepsy

Electroclinical study of patients with juvenile absence epilepsy

Childhood Absence Epilepsy: Elctroclinical Features and Diagnostic Criteria

Clinical and Video - Electroencephalogram Features of Childhood Absence Epilepsy and Its Diagnostic Criteria Investigation

P.102 Childhood Absence Epilepsy: Prevalence of treatment resistance and neuropsychiatric comorbidity.

Ictal Source Locations and Cortico–Thalamic Connectivity in Childhood Absence Epilepsy: Associations with Treatment Response

The Treatment and Prognosis of Myoclonic Atonic Epilepsy.

Features of clinical and therapy in juvenile myoclonic epilepsy: an analysis of 87 cases

Clinical and electroencephalographic features of myoclonic-astatic epilepsy

Clinical Features and Treatment of Epilepsy with Myoclonic-Atonic Seizures in Children

Early onset absence epilepsy of childhood: Epidemiologic data, treatment and outcome in a sample of 56 patients born between 2000 and 2018

Genetic progress of childhood absence epilepsy

Response to Antiseizure Medications in Epileptic Patients with Malformation of Cortical Development

Absence Seizures During Sleep in Childhood Absence Epilepsy: A Sign of Drug Resistance?

De Novo SCN1A, SCN8A, and CLCN2 Mutations in Childhood Absence Epilepsy.

Clinical Features of Benign Epilepsy of Childhood with Centrotemporal Spikes in Chinese Children.

Longterm follow-up of childhood epilepsy with absences. II. Absence-epilepsy with initial grand mal

Neurocognitive Profiles In Childhood Absence Epilepsy: A Focus On Cognitive Dysfunction Associated With The Frontal Lobe

Study on the Prognosis and Related Factors of Epilepsy in Long-Term Follow-Up Children

Analysis of 247 Children with Status Epilepticus: Clinical Features and Prognosis